Hoth Therapeutics Stock Analysis

HOTH Stock  USD 1.26  0.02  1.56%   
Hoth Therapeutics is undervalued with Real Value of 2.07 and Target Price of 4.5. The main objective of Hoth Therapeutics stock analysis is to determine its intrinsic value, which is an estimate of what Hoth Therapeutics is worth, separate from its market price. There are two main types of Hoth Therapeutics' stock analysis: fundamental analysis and technical analysis.
The Hoth Therapeutics stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Hoth Therapeutics' ongoing operational relationships across important fundamental and technical indicators.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hoth Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For more detail on how to invest in Hoth Stock please use our How to Invest in Hoth Therapeutics guide.

Hoth Stock Analysis Notes

The company has price-to-book (P/B) ratio of 1.14. Some equities with similar Price to Book (P/B) outperform the market in the long run. Hoth Therapeutics recorded a loss per share of 1.27. The entity had not issued any dividends in recent years. The firm had 1:25 split on the 26th of October 2022. Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs. Hoth Therapeutics, Inc. was incorporated in 2017 and is headquartered in New York, New York. Hoth Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 4 people. To learn more about Hoth Therapeutics call the company at 646 756 2997 or check out https://hoththerapeutics.com.

Hoth Therapeutics Investment Alerts

Hoth Therapeutics is way too risky over 90 days horizon
Hoth Therapeutics may become a speculative penny stock
Hoth Therapeutics appears to be risky and price may revert if volatility continues
Net Loss for the year was (7.85 M) with profit before overhead, payroll, taxes, and interest of 0.
Hoth Therapeutics currently holds about 11.62 M in cash with (8.45 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.02, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Hoth Therapeutics has a frail financial position based on the latest SEC disclosures
Latest headline from news.google.com: Hoth Therapeutics Regains Compliance with Nasdaq Listing Requirements - PR Newswire

Hoth Therapeutics Upcoming and Recent Events

Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Hoth Therapeutics previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
29th of March 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View

Hoth Largest EPS Surprises

Earnings surprises can significantly impact Hoth Therapeutics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2023-11-13
2023-09-30-0.72-0.60.1216 
2024-08-09
2024-06-30-0.43-0.240.1944 
2024-03-28
2023-12-31-0.51-0.320.1937 
View All Earnings Estimates

Hoth Stock Institutional Investors

Shares
Wells Fargo & Co2024-09-30
2.0
Qube Research & Technologies2024-09-30
0.0
Armistice Capital, Llc2024-09-30
0.0
Hrt Financial Llc2024-09-30
121.9 K
Geode Capital Management, Llc2024-09-30
82.9 K
Ubs Group Ag2024-09-30
56.5 K
Vanguard Group Inc2024-09-30
38.8 K
Virtu Financial Llc2024-09-30
32.6 K
Two Sigma Securities, Llc2024-09-30
18.6 K
Morgan Stanley - Brokerage Accounts2024-09-30
10.3 K
Tower Research Capital Llc2024-09-30
4.5 K
Note, although Hoth Therapeutics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Hoth Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 8.84 M.

Hoth Profitablity

Last ReportedProjected for Next Year
Return On Tangible Assets(0.74)(0.78)
Return On Capital Employed(0.78)(0.82)
Return On Assets(0.74)(0.78)
Return On Equity(0.80)(0.84)

Management Efficiency

Hoth Therapeutics has return on total asset (ROA) of (0.4616) % which means that it has lost $0.4616 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.8341) %, meaning that it created substantial loss on money invested by shareholders. Hoth Therapeutics' management efficiency ratios could be used to measure how well Hoth Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.78. The current Return On Capital Employed is estimated to decrease to -0.82. As of now, Hoth Therapeutics' Net Tangible Assets are increasing as compared to previous years. The Hoth Therapeutics' current Non Current Assets Total is estimated to increase to about 188.9 K, while Total Assets are projected to decrease to under 5.8 M.
Last ReportedProjected for Next Year
Book Value Per Share 2.33  4.27 
Tangible Book Value Per Share 2.33  4.27 
Enterprise Value Over EBITDA 25.43  26.71 
Price Book Value Ratio 0.64  0.61 
Enterprise Value Multiple 25.43  26.71 
Price Fair Value 0.64  0.61 
Enterprise Value-5 M-4.7 M
Understanding the operational decisions made by Hoth Therapeutics management offers insights into its financial robustness. This evaluation is crucial for assessing the stock's investment potential.
Beta
0.844
Return On Assets
(0.46)
Return On Equity
(0.83)

Technical Drivers

As of the 1st of February, Hoth Therapeutics retains the Risk Adjusted Performance of 0.0798, downside deviation of 5.99, and Market Risk Adjusted Performance of (0.96). Hoth Therapeutics technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.

Hoth Therapeutics Price Movement Analysis

Execute Study
The output start index for this execution was twenty-nine with a total number of output elements of thirty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Hoth Therapeutics middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Hoth Therapeutics. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Hoth Therapeutics Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Hoth Therapeutics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Hoth Therapeutics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Hoth Therapeutics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Hoth Therapeutics Outstanding Bonds

Hoth Therapeutics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Hoth Therapeutics uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Hoth bonds can be classified according to their maturity, which is the date when Hoth Therapeutics has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Hoth Therapeutics Predictive Daily Indicators

Hoth Therapeutics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Hoth Therapeutics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Hoth Therapeutics Forecast Models

Hoth Therapeutics' time-series forecasting models are one of many Hoth Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Hoth Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Hoth Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Hoth Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Hoth shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Hoth Therapeutics. By using and applying Hoth Stock analysis, traders can create a robust methodology for identifying Hoth entry and exit points for their positions.
Last ReportedProjected for Next Year

Current Hoth Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Hoth analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Hoth analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
4.5Strong Buy1Odds
Hoth Therapeutics current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Hoth analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Hoth stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Hoth Therapeutics, talking to its executives and customers, or listening to Hoth conference calls.
Hoth Analyst Advice Details

Hoth Stock Analysis Indicators

Hoth Therapeutics stock analysis indicators help investors evaluate how Hoth Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Hoth Therapeutics shares will generate the highest return on investment. By understating and applying Hoth Therapeutics stock analysis, traders can identify Hoth Therapeutics position entry and exit signals to maximize returns.
Begin Period Cash Flow6.4 M
Common Stock Shares Outstanding3.4 M
Total Stockholder Equity8.8 M
Property Plant And Equipment Net55.2 K
Cash And Short Term Investments9.3 M
Cash9.3 M
Accounts Payable35.6 K
Net Debt-9.2 M
50 Day M A1.0393
Total Current Liabilities678.7 K
Other Operating Expenses7.7 M
Non Current Assets Total92.6 K
Non Currrent Assets Other-1.00
Stock Based Compensation216.4 K

Complementary Tools for Hoth Stock analysis

When running Hoth Therapeutics' price analysis, check to measure Hoth Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hoth Therapeutics is operating at the current time. Most of Hoth Therapeutics' value examination focuses on studying past and present price action to predict the probability of Hoth Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hoth Therapeutics' price. Additionally, you may evaluate how the addition of Hoth Therapeutics to your portfolios can decrease your overall portfolio volatility.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Bonds Directory
Find actively traded corporate debentures issued by US companies
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account